CMCIA Appoints New Executive Director - Colette Rivet to Lead Medical Cannabis Industry Association

OTTAWA, Jan. 13, 2016 /CNW Telbec/ - The Board of Directors of the Canadian Medical Cannabis Industry Association (CMCIA) has announced the appointment of Colette Rivet as the new Executive Director of the Association.

Ms. Rivet is an experienced association leader with a deep background in health matters, having served previously as Executive Director of Resident Doctors of Canada and BioTalent Canada, in addition to senior roles with the Canadian Centre on Substance Abuse (CCSA), the Canadian Institutes of Health Research (CIHR), the Royal College of Physicians and Surgeons, and the Canadian Blood Agency. Fluently bilingual, Ms. Rivet has a Masters of Business Administration from the University of Ottawa, and has obtained a Certified Health Executive certification from the Canadian College of Health Service Executives.

"We are very pleased to welcome Colette to CMCIA at a pivotal time for the medical cannabis industry, and for medical cannabis patients," said Marc Wayne, Chair of the Board of CMCIA. "She has the experience, insight and drive to lead the Association's initiatives to protect and enhance Canada's national medical cannabis system, and to bring our members' vast expertise to the public policy discussions around legalization of non-medical cannabis."

About CMCIA

The Canadian Medical Cannabis Industry Association (CMCIA) is Canada's leading member-driven association for Licensed Producers (LPs) of medical cannabis. The Association represent the majority of producers currently licensed under Health Canada's Marijuana for Medical Purposes Regulations (MMPR).

CMCIA's mission is to promote national standards and best practices by supporting the development, growth and integrity of the medical cannabis industry. The Association acts as the national voice for Canada's LPs, and serves as a credible and trusted resource on issues related to medical cannabis industry.

The Association shares a philosophy of patient-centric care and improved public health, and is committed to product safety and quality, secure and reliable access for registered patients, and the promotion of the safe and effective use of cannabis for medical purposes. www.cmcia.ca

SOURCE Canadian Medical Cannabis Industry Association

Cam Battley, Chair, Communications Committee, CMCIA, [email protected], 905.864.5525